Search - tctmd.com

Displaying 281 - 300 of 548

Sort: Relevancy | Date

News Daily News

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications

Michael O'Riordan

May 06, 2022

News Conference News HRS 2022

Evidence Grows for Conduction-System Pacing as an Alternative to CRT

Todd Neale

May 05, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Caitlin E. Cox

May 03, 2022

News Conference News HRS 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Todd Neale

May 02, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Daily News

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Michael O'Riordan

April 22, 2022

News Daily News

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

Caitlin E. Cox

April 15, 2022

News Conference News ACC 2022

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

L.A. McKeown

April 07, 2022

Seasonal, but No Year-round, Protection With Flu Shots in HF: IVVE

News Conference News ACC 2022

Seasonal, but No Year-round Help for HF With Flu Shots: IVVE

Yael L. Maxwell

April 03, 2022

SODIUM-HF: No Impact of Dietary Salt Restriction on Death or Hospitalization

News Conference News ACC 2022

SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization

L.A. McKeown

April 02, 2022

News Daily News

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

Michael O'Riordan

March 28, 2022

News Conference News ACC 2022

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Shelley Wood

March 28, 2022

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Skipping Second Dose of mRNA COVID-19 Vaccine May Limit Myocarditis in Adolescents

Todd Neale

February 25, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

Advertisement

The Hunt for Protein Culprits in COVID-19’s Cardiac Complications

Evidence Grows for Conduction-System Pacing as an Alternative to CRT

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

May 2022 News Roundup

CVD Hospitalizations Spiked in Aftermath of 2020 US Election

Revascularization’s Benefits in HFrEF Linked to Gains in LV Function

QoL Gains Within 15 Days in Acute HF With Empagliflozin: EMPULSE Analysis

Seasonal, but No Year-round Help for HF With Flu Shots: IVVE

SODIUM-HF: No Impact of Tighter Dietary Salt Restriction on Death or Hospitalization

Prognosis of Myocarditis Following COVID-19 Vaccination ‘Favorable’

What’s Going to Be Hot at ACC 2022, In Person or Virtual

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Guideline-Directed Therapies Underused in Frail HF Patients

Skipping Second Dose of mRNA COVID-19 Vaccine May Limit Myocarditis in Adolescents

FDA Approves Empagliflozin for Treatment of HFpEF

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Modified Surgical MV Repair Stands Up to Replacement

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content